Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWest.brom 6.15% Regulatory News (WBS)

Share Price Information for West.brom 6.15% (WBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.50
Bid: 82.00
Ask: 87.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.098%)
Open: 84.50
High: 84.50
Low: 84.50
Prev. Close: 84.50
WBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Reorganisation

10 Apr 2018 11:00

RNS Number : 4106K
West Bromwich Building Society
10 April 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES, AUSTRALIA, SOUTH AFRICA, JAPAN, HONG KONG, SINGAPORE, ITALY, SWITZERLAND OR CANADA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION

Regulatory News Announcement

For Immediate Release10 April 2018

West Bromwich Building Society[1]FINAL RESULTS OF Liability Management Exercise

This announcement contains inside information.

In an announcement dated 8 March 2018 (the "March Announcement"), West Bromwich Building Society (the "Society") announced the launch of its liability management exercise (the "Liability Management Exercise" or "LME") in relation to its 3,650 Profit Participating Deferred Shares (the "PPDS") and its £75 million 6.15 per cent. Permanent Interest Bearing Shares (the "PIBS").

The LME consists of the PPDS Exchange Offer and the PIBS Exchange Offer (together, the "Exchange Offers"), the PIBS Tender Offer (together with the Exchange Offers, the "Offers") and the Variations, in each case as defined in the March Announcement. The full terms of the Exchange Offers were set out in a Consent and Exchange Offer Memorandum (the "CEOM") and the full terms of the PIBS Tender Offer were set out in a Consent and Tender Offer Memorandum (the "CTOM"), in each case dated 8 March 2018. Defined terms used and not otherwise defined in this announcement have the meanings given in the March Announcement, the CEOM or the CTOM.

On 6 April 2018, the Society announced the indicative results of the LME. The Society is now announcing the final results of the LME.

Final Results of the LME

PRA approvals and settlement conditions

Following conclusion of the PIBS Meeting held on 9 April 2018, the Society informed the Prudential Regulation Authority ("PRA") of the outcome of the LME. The Society has now received all final approvals from the PRA which are necessary for it to settle the LME.

The Society also confirms that the Settlement Conditions to the Offers, as set out in the CEOM and CTOM, have been or will be satisfied or waived on or prior to the Settlement Date.

Participation and acceptance

As at the Participation Deadline for the Offers:

(i) a total of 3,650 PPDS (representing 100 per cent. of the total number of PPDS outstanding) had been validly Offered for Exchange pursuant to the PPDS Exchange Offer;

(ii) £58,032,000 in aggregate nominal amount of the PIBS (representing 77.38 per cent. of the aggregate nominal amount of the PIBS outstanding) had been validly Offered for Exchange pursuant to the PIBS Exchange Offer; and

(iii) £8,077,000 in aggregate nominal amount of the PIBS (representing 10.77 per cent. of the aggregate nominal amount of the PIBS outstanding) had been validly tendered for purchase pursuant to the PIBS Tender Offer.

The Society hereby confirms that it accepts for exchange all of the PPDS and PIBS which were validly Offered for Exchange in the Exchange Offers and accepts for purchase all of the PIBS which were validly tendered for purchase in the PIBS Tender Offer.

PIBS Meeting

The PIBS Meeting was held at 5.30 p.m. on 9 April 2018. More than one-third of the PIBS outstanding were represented at the PIBS Meeting, and the votes cast in favour of the Extraordinary Resolution (in the form set out at Annex A to the CEOM and Annex 2 to the CTOM) represented more than three-quarters of the PIBS represented at the PIBS Meeting. Accordingly, the Extraordinary Resolution was duly passed.

The Society has, accordingly, varied the PIBS Conditions with immediate effect, and the revised PIBS Conditions are available for viewing on the Society's website.

PPDS Written Resolutions

As announced on 6 April 2018 the PPDS Written Resolutions, as set out at Annex B to the CEOM, were duly passed on 5 April 2018 with the consent in writing of the holders of more than three-quarters of the PPDS.

Following receipt of the PRA approvals, the Society has, accordingly, varied the PPDS Conditions with immediate effect, and the revised PPDS Conditions are available for viewing on the Society's website.

Given that all of the PPDS have been validly Offered for Exchange and accepted pursuant to the PPDS Exchange Offer, there are no further PPDS in respect of which the Sweep-up Option could be exercised, and accordingly such option will not be exercised.

Settlement of the Offers

The Offers are scheduled to settle on 12 April 2018 (the "Settlement Date"). As a result of the Offers, the Society expects that, on the Settlement Date, it will:

(i) issue a total of 1,288,813 Core Capital Deferred Shares ("CCDS");

(ii) issue £22,498,600 in aggregate nominal amount of Tier 2 Notes;

(iii) make total Cash Payments equal to £29,257,257.18 pursuant to the Exchange Offers; and

(iv) make total Aggregate Cash Payments equal to £4,200,040 pursuant to the PIBS Tender Offer.

The Society will make an application for the CCDS and the Tier 2 Notes to be admitted to the Official List of the Luxembourg Stock Exchange and admitted to trading on its Euro MTF Market with effect on or around the Settlement Date.

The Society also expects that, as a result of the Offers, it will on the Settlement Date cancel all of the outstanding PPDS and cancel £66,109,000 in aggregate nominal amount of the PIBS. Accordingly, following the Settlement Date, no PPDS will remain outstanding and £8,891,000 in aggregate nominal amount of the PIBS will remain outstanding.

Based upon the results of the LME, the Society anticipates that, on an indicative basis only (had the LME been successfully completed on 30 September 2017) its common equity tier 1 ("CET1") ratio would have been maintained at 14.1 per cent., its total capital ratio (with full impact of CRD IV implementation) would have increased by approximately 1 percentage point to 15.8 per cent. and Member Reserves would have increased by approximately £50 million, before any accounting adjustment to other reserves to reflect the fair values of the new instruments.

Jonathan Westhoff, Chief Executive of the Society, said:

"I am delighted that we have been able to announce the successful outcome of the LME today, well within our target of the first half of 2018. The Board would like to thank our PPDS and PIBS holders for their tremendous support in making the LME a success. Following this modernisation of the Society's capital base, we look forward to focusing on the continued delivery of our plan to provide exceptional lending and savings products to our membership."

Market Abuse Regulation

This announcement is released by West Bromwich Building Society and contains information that qualifies or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the Liability Management Exercise described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, the person responsible for arranging the release of this announcement on behalf of West Bromwich Building Society is Ashraf Piranie, Group Finance & Operations Director.

DISCLAIMER

The offer period for each of the Offers has now expired. The Offers have been made outside the United States and otherwise subject to offer restrictions in South Africa, Japan, Hong Kong, Singapore, Italy, Switzerland, Canada and elsewhere.

MiFID II product governance - professional investors and ECPs only target market / PRIIPs Regulation - prohibition of sales to EEA retail investors / COBS 22.2 - restriction on marketing and sales to retail investors

The securities to be issued pursuant to the LME have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws. Accordingly, the securities are and will be subject to restrictions on transferability and resale and may not be transferred or resold except as permitted under the Securities Act and other applicable securities laws, pursuant to an exemption from registration. Registration rights will not be granted in favour of the securities and they may not be offered, sold, pledged or otherwise transferred except outside the United States in accordance with Rule 903 or Rule 904 of Regulation S.

This announcement and any other materials relating to the Offers may only be communicated to persons in the United Kingdom in circumstances where section 21(1) of the Financial Services and Markets Act 2000 does not apply.

This announcement and any other materials relating to the Offers are and will be for the personal use of authorised recipients only. Under no circumstances should any such documents or materials be reproduced or distributed to any other persons. Persons into whose possession any such documents or materials come are required to inform themselves about and to observe any such restrictions. This announcement and any other materials relating to the Offers do not constitute, and may not be used for the purpose of, an offer or solicitation to the public or to anyone in any jurisdiction in which such offer or solicitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation.


[1] LEI: 45WSBJJYVGC91LG3H515

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CARFKKDPFBKKDQD
Date   Source Headline
25th Mar 202412:09 pmRNSAnnouncement to Listing Authorities
30th Nov 20238:00 amRNSHalf-year results for the six months to 30 Sept 23
12th Sep 202312:56 pmRNSAnnouncement to Listing Authorities
1st Aug 20232:14 pmRNSAppointment of Non Executive Director
17th Jul 202311:59 amRNSPARTIAL REPURCHASE OF NOTES - REPLACEMENT
17th Jul 202311:16 amRNSPARTIAL REPURCHASE OF SUBORDINATED FIXED RATE NOTE
26th Jun 20233:54 pmRNSStatement re (add text)
1st Jun 20238:00 amRNSFinal Results
15th May 20232:18 pmRNSNotice of Optional Redemption
13th Mar 20233:02 pmRNSAnnouncement to Listing Authorities
7th Dec 20224:21 pmRNSDirectorate Change
7th Dec 20224:05 pmRNSHalf-year Report
7th Sep 20223:56 pmRNSAnnouncement to Listing Authorities
26th May 20227:30 amRNSDirectorate Change
26th May 20227:30 amRNSFinal Results
9th Mar 20223:32 pmRNSPIBS Interest Payment
24th Nov 20213:04 pmRNSHalf-year Report
24th Nov 20213:03 pmRNSDistribution Announcement CCDS
30th Sep 20219:15 amRNSCancellation of Interest Payments
28th Jul 20213:43 pmRNSDirectorate Change
27th May 20219:07 amRNSDistribution Announcement CCDS
27th May 20218:55 amRNSFinal Results
26th May 20212:03 pmRNSDirectorate Change
18th Mar 20218:44 amRNSCancellation of interest payments
5th Mar 20217:00 amRNSDirectorate Change
30th Dec 202011:46 amRNSBoard Change
26th Nov 20203:29 pmRNSDistribution Announcement CCDS
26th Nov 20203:21 pmRNSHalf-year Report
1st Oct 202010:15 amRNSCancellation of Interest Payments
22nd Jul 20204:06 pmRNSPIBS buy back and cancellation
2nd Jun 20202:16 pmRNSFinal Results
26th Mar 20209:20 amRNSCancellation of Interest Payments
20th Jan 20204:19 pmRNSUpdate on PIBS Distribution Policy
26th Nov 20191:27 pmRNSHalf-year Report
2nd Oct 20192:58 pmRNSCancellation of Interest Payments
29th May 20193:21 pmRNSFinal Results
29th Mar 20192:30 pmRNSCancellation of Interest Payments
6th Dec 20182:34 pmRNSHalf-year Report
26th Sep 20184:51 pmRNSCancellation of Interest Payment
30th May 20183:11 pmRNSFinal Results
10th Apr 201811:00 amRNSCapital Reorganisation
6th Apr 201811:00 amRNSCapital Reorganisation
28th Mar 20183:50 pmRNSCancellation of Interest Payment
8th Mar 20181:15 pmRNSCapital Reorganisation
19th Jan 20183:18 pmRNSProfit Participating Deferred Shares
13th Dec 20171:28 pmRNSCapital Reorganisation
28th Nov 20171:58 pmRNSHalf-year Report
29th Sep 201710:15 amRNSCancellation of Interest Payment
30th May 20172:45 pmRNSFinal Results
25th Apr 201710:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.